U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958224) titled 'Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers' on April 16.
Brief Summary: The European Society for Medical Oncology (ESMO) strongly recommends to develop multigene sequencing in the framework of molecular screening programmes, in order to improve access to innovative drugs and to accelerate clinical research in cancers.
* Accordingly, this project aims to study the contribution of early systematic multigene sequencing (NGS) discussed in Molecular Tumour Board for poor prognosis cancers, with no current indication for early sequencing.
* The investigators teams propose to perform a randomized ...